or Try an Advanced Search...

    Technical Analysis for EOLS - Evolus, Inc.

    Grade Last Price % Change Price Change
    F 12.73 0.75% 0.10
    EOLS closed up 1.94 percent on Wednesday, November 20, 2024, on 64 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical EOLS trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.75%
    Wide Bands Range Expansion 0.75%
    Oversold Stochastic Weakness 0.75%
    Wide Bands Range Expansion 2.70%
    Oversold Stochastic Weakness 2.70%
    180 Bearish Setup Bearish Swing Setup 6.13%
    Slingshot Bearish Bearish Swing Setup 6.13%
    Lower Bollinger Band Walk Weakness 6.13%
    Wide Bands Range Expansion 6.13%
    Oversold Stochastic Weakness 6.13%
    Older End-of-Day Signals for EOLS ...

       Recent Intraday Alerts

    Alert Time
    Up 2% 17 minutes ago
    Rose Above Previous Day's High 24 minutes ago
    Rose Above 10 DMA 24 minutes ago
    Up 1% 24 minutes ago
    Possible NR7 about 20 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EOLS Chart by TradingView
    Basic chart:

    Profile

    Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Clinical Medicine Toxins Plastic Surgery Botulinum Toxin Botulism Neurotoxins

    Is EOLS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher
    Nov 14 Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS)
    Nov 9 Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
    Nov 8 Evolus Third Quarter 2024 Earnings: Misses Expectations
    Nov 7 Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges
    Nov 7 Evolus, Inc. (EOLS) Q3 2024 Earnings Conference Call Transcript
    Nov 6 Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates
    Nov 6 Evolus GAAP EPS of -$0.30 misses by $0.11, revenue of $61.1M misses by $2.3M
    Nov 6 Evolus Reports Third Quarter 2024 Results
    Nov 5 Evolus Q3 2024 Earnings Preview
    See more EOLS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.82
    52 Week Low 9.29
    Average Volume 670,601
    200-Day Moving Average 13.73
    50-Day Moving Average 15.75
    20-Day Moving Average 14.58
    10-Day Moving Average 12.68
    Average True Range 0.76
    RSI (14) 33.77
    ADX 29.5
    +DI 15.63
    -DI 35.57
    Chandelier Exit (Long, 3 ATRs) 15.16
    Chandelier Exit (Short, 3 ATRs) 13.65
    Upper Bollinger Bands 18.54
    Lower Bollinger Band 10.61
    Percent B (%b) 0.25
    BandWidth 54.36
    MACD Line -1.12
    MACD Signal Line -0.86
    MACD Histogram -0.2626
    Fundamentals Value
    Market Cap 729.52 Million
    Num Shares 57.8 Million
    EPS -1.12
    Price-to-Earnings (P/E) Ratio -11.28
    Price-to-Sales 4.28
    Price-to-Book 25.65
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 13.35
    Resistance 3 (R3) 13.28 12.96 13.23
    Resistance 2 (R2) 12.96 12.78 13.00 13.19
    Resistance 1 (R1) 12.80 12.67 12.88 12.87 13.15
    Pivot Point 12.48 12.48 12.53 12.52 12.48
    Support 1 (S1) 12.32 12.30 12.40 12.39 12.11
    Support 2 (S2) 12.00 12.19 12.04 12.07
    Support 3 (S3) 11.84 12.00 12.03
    Support 4 (S4) 11.91